Peroxisome proliferator activated receptor-γ (PPARγ) represses thyroid hormone signaling in growth plate chondrocytes

被引:20
|
作者
Wang, L [1 ]
Shao, YY [1 ]
Ballock, RT [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Orthopaed Res Ctr, Dept Orthopaed Surg & Biomed Engn, Cleveland, OH 44195 USA
关键词
growth plate chondrocyte; peroxisome proliferator activated receptor-gamma; thyroid hormone;
D O I
10.1016/j.bone.2005.04.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator activated receptors (PPARs) are DNA-binding nuclear hormone receptors that are upregulated in response to high fat diets. PPARs are structurally related to the type II nuclear receptors, including the thyroid hormone receptors (TRs). To investigate if PPARs modulate TR-mediated terminal differentiation of growth plate chondrocytes, primary cultures of epiphyseal chondrocytes transiently transfected with TR alpha and PPAR gamma expression vectors were treated with the PPAR ligands ciglitazone or troglitazone. Forced overexpression of PPAR gamma decreased TR alpha 1-mediated transcriptional activity and suppressed T3-induced increases in alkaline phosphatase activity and type X collagen expression. Similar effects were observed when the cells were treated with the PPAR gamma activator ciglitazone or troglitazone. Overexpression of retinoid X receptor-alpha (RXR alpha) partially restored not only the inhibition of transcriptional activation by PPAR gamma but also T3-induced hypertrophic differentiation. These data demonstrate that activation of PPAR gamma signaling by either addition of PPAR gamma ligands or overexpression of PPAR gamma in growth plate chondrocytes inhibits TR-mediated gene transcription and inhibits the biological effects of thyroid hormone on terminal differentiation. The molecular mechanism involved in this inhibition appears to be competition between PPAR gamma and TR alpha for limiting amounts of the heterodimeric partner RXR. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
    Zhang, Feng
    Kong, Desong
    Lu, Yin
    Zheng, Shizhong
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (02) : 259 - 276
  • [42] Endotoxin downregulates peroxisome proliferator-activated receptor-γ via the increase in TNF-α release
    Zhou, Mian
    Wu, Rongqian
    Dong, Weifeng
    Jacob, Asha
    Wang, Ping
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 294 (01) : R84 - R92
  • [43] Relationship between peroxisome proliferator-activated receptor-γ mRNA expression and intracranial aneurysm rupture
    Zhang, Xiong
    Kang, Yan-Xun
    Kong, Wei
    Zhang, Ya-Lan
    Ju, Tao
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [44] Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats
    Su, Xuesong
    Yu, Rui
    Yang, Xu
    Zhou, Guangyu
    Wang, Yanqiu
    Li, Li
    Li, Detian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (06) : 671 - 679
  • [45] Peroxisome proliferator-activated receptor-γ:: therapeutic target for diseases beyond diabetes:: quo vadis?
    Pershadsingh, HA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (03) : 215 - 228
  • [46] Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-γ
    Pershadsingh, HA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (5-6) : 766 - 781
  • [47] The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy
    Chiang, Cho-Han
    Chang, Yu-Cheng
    Wang, Shih-Syuan
    Chen, Yuan-Jen
    See, Xin Ya
    Peng, Chun-Yu
    Hsia, Yuan Ping
    Chiang, Cho-Hsien
    Chiang, Cho-Hung
    Peng, Cheng-Ming
    CANCER MEDICINE, 2023, 12 (08): : 9583 - 9588
  • [48] Hepatic Steatosis with Relation to Increased Expression of Peroxisome Proliferator-Activated Receptor-γ in Insulin Resistant Mice
    Satoh, Hikaru
    Ide, Naohito
    Kagawa, Yoshiyuki
    Maeda, Toshio
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (04) : 616 - 623
  • [49] Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice
    Lv, Xin
    Song, Jian-Gang
    Li, Hong-Hai
    Ao, Jun-Ping
    Zhang, Ping
    Li, Ye-Sheng
    Song, Shao-Li
    Wang, Xiang-Rui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (48) : 5267 - 5273
  • [50] Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, reduces acute lung injury in endotoxemic rats
    Liu, D
    Zeng, BX
    Zhang, SH
    Wang, YL
    Zeng, L
    Geng, ZL
    Zhang, SF
    CRITICAL CARE MEDICINE, 2005, 33 (10) : 2309 - 2316